PRGO Earnings

PRGO reported its FY2025Q4 earnings on 2026-03-02, showcasing a revenue of against an estimate of 1.17B, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.8 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following PRGO's FY2025Q4 earnings announcement on 2026-03-02, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, PRGO's stock price tends to shift by an average of +7.34% in the 10 days leading up to earnings and +0.76% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate PRGO’s annual revenue to reach 1.10B, while the EPS is projected at 0.78. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by -0% and EPS estimates No Change by 0% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between PRGO's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were No Change by -0%, while EPS estimates moved No Change by 0% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, PRGO's stock price typically moves by +7.34% in the 10 days before its earnings and +0.76% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.78 and revenue of 1.10B.

The earnings call reveals mixed signals. Basic financial performance shows some decline in gross profit and margin, but EPS grew slightly. Product development is hindered by slower-than-expected recovery in Infant Formula. Market strategy shows potential with new SKUs, though facing execution challenges. Expenses are managed well, but tariffs are a concern. The shareholder return plan remains stable. Q&A highlights management's unclear responses on critical issues, adding uncertainty. Overall, the sentiment is neutral, with no significant catalysts or detractors to drive the stock price significantly in either direction.